An array of leading domestic and global pharmaceutical companies routinely turn to Liad Whatstein & Co. Law Office for its experience in filing and prosecuting patents. The team also displays significant expertise in managing trademark portfolios on behalf of major media and entertainment companies. Alongside his specialism in patent prosecution, Liad ‎ Whatstein is also noted for handling trademarks disputes, while Amira Mangelus is praised by clients for her ‘extensive experience in complex cross-border litigation’, most notably in the life sciences sector. Oren Weiner is an expert in the patent term extension system.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Liad Whatstein is a technically excellent, diligent and dedicated partner who is always available. He spends time personally with experts, develops arguments and produces excellent pleadings. He adds the strategic aspect of litigation to litigation.'
  • 'Amira Mangelus has a technical background and extensive experience in complex cross-border litigation. She is one of the founding partners of the firm and provides pragmatic advice.'
  • 'Liad Whatstein is one of the best, if not the best, patent litigation firm in Israel.'

  • 'The team is technically proficient in a wide range of life sciences technologies, inter alia, due to its extensive experience in most major life sciences litigation in Israel and involvement in numerous cross-border proceedings. Familiarity with cross-border litigation is helpful.'

  • 'The firm has acquired an in-depth knowledge of the Israel Court and ILPTO procedures and how to cross-examine experts. It utilises its litigation expertise in prosecuting patent applications, providing in-depth analysis of office actions, proactively discussing objections with examiners and successfully reducing the number of cycles of office actions.'

Key clients

  • Novartis
  • Sanofi
  • Merck
  • Pfizer
  • Roche
  • Bristol Myers
  • Takeda
  • Regeneron
  • Abbott
  • Bayer
  • Biogen
  • Astellas
  • Alkermes
  • UCB Pharma
  • Alnylam Pharmaceuticals
  • H. Lundbeck A/S
  • Leo Pharma
  • Genzyme
  • Novo Nordisk
  • L’Oréal
  • Unilever
  • Amdocs
  • The State of Israel
  • The Hebrew University
  • Sony
  • Viacom
  • LVMH
  • Disney
  • Volvo
  • Yokogawa Electric Corporation
  • Hearst Corporation
  • Fruit of the Loom
  • Bacardi
  • CROCS
  • Ralph Lauren
  • Kipling
  • Tory Burch
  • Paramount Pictures Corporation
  • The H.D. Lee Company
  • Wrangler Apparel Corp.
  • The North Face Apparel Corp.
  • Jansport Apparel Corp.
  • Nautica
  • Renault
  • VANS
  • eBay
  • Kanye West
  • Brown Forman (Jack Daniel’s)
  • Finlandia Vodka
  • Grey Goose Vodka
  • Spin Master
  • Moose Toys
  • Elbit Systems
  • Finchimica
  • InterMune
  • ASSA ABLOY
  • NBC Universal
  • 20th Century Fox
  • Marvel
  • Dr. Fischer Pharmaceuticals
  • Altra
  • Triumph Motorcycles
  • Harvard University
  • Prudential plc
  • Fleurop-Interflora
  • Homag Group AG
  • Immunogen Inc.
  • Advanced Accelerator Applications (a Novartis Corporation)
  • Eden Gallery
  • Fox-Weizel (Israel’s largest chain of apparel outlets)
  • HID Corporation (Assa Abloy company)
  • Saban Group
  • MIT (Massachusetts Institute of Technology)
  • University of Georgia Research Foundation, Inc.
  • Memo Therapeutics AG
  • Axcella Health Inc.
  • Innate PharmaS.A.
  • Principia Biopharma Inc.
  • Translate Bio, Inc
  • Ryvu Therapeutics S.A.
  • Acceleron Pharma, Inc.
  • Arbor Biotechnologies, Inc.
  • Kymab Ltd.
  • ZURU Toys
  • Belvedere Vodka
  • Alusense N.V. / Belmoca N.V.
  • Hey Dude
  • Konti
  • Lipton Teas and Infusions
  • Tux Creative Co.
  • Degussa Bank A.G.

Work highlights

  • Prosecuted non-traditional trademarks (3-Dimensional product shapes, slogans, color combinations, product trade-dress, etc.) for numerous international brand owners, such as Crocs and Abbott.
  • Prosecuted highly complex petitions for patent term extension (PTE) for numerous major clients, including Merck and Novartis.
  • Obtained allowance of strategic patent applications relating to various dosage forms and dosage regimens for major pharmaceutical clients, including Novartis and Pfizer and many others.

Practice head

The lawyer(s) leading their teams.

Liad Whatstein, Amira Mangelus

Other key lawyers

Oren Weiner